ANDREW WEISS, MBA President & Chief Executive Officer
Andrew Weiss joined ReCor Medical in April 2013.
Mr. Weiss brings over 20 years experience in the Medical Device Industry, starting with global management responsibilities at GE Medical Systems. Mr. Weiss left GE to become Vice President of Sales & Marketing at Marquette Medical Systems. Following Marquette, Mr. Weiss became President & CEO of Vital Images, a company he took public in 1996. Mr. Weiss then joined Medtronic as VP & General Manager of its Surgical Navigation Systems business, following which he became VP & General Manager of the Medtronic Neurological business. Prior to joining ReCor Medical, Mr. Weiss served as President & CEO of CoAxia, Inc. Mr. Weiss is a graduate of the Massachusetts Institute of Technology with a degree in mechanical and electrical engineering and has an MBA from the Columbia University Graduate School of Business.
MANO IYER, MBA Founder
Mano Iyer is a founder of ReCor Medical.
Mr. Iyer served as Entrepreneur-In-Residence at Sofinnova Partners, a life science venture capital firm, in Paris, France since 2008. Mr. Iyer has spent the last 20 years working in the Medical Device Industry in various engineering, operational, and investment roles in the US, France, Germany, Switzerland, the Czech Republic, and the Netherlands, for public and private enterprises. He is a co-founder of Contract Medical International in Germany and a former Investment Manager at MD Start, a European-based medical device accelerator. Mr. Iyer has a BS in Mechanical Engineering from the Rochester Institute of Technology and an MBA from the Stanford Graduate School of Business.
MATTHEW J. FRANKLIN, MBA Chief Financial Officer
Matt Franklin joined ReCor Medical in June 2015.
Mr. Franklin has been CFO of numerous venture-backed companies including most recently serving as CFO of myoscience (therapeutics/aesthetics) for six years. He specializes in helping Pre-IPO companies get through initial commercialization. In 2000, he co-founded, CFO Connection, a financial services firm that assists technology and medtech companies in successfully building their businesses. Prior to CFO Connection he was ACLARA BioSciences’ (medtech) top financial officer for four years. Earlier in his career he was Co-Founder and CFO at BioLumin Corporation (sold to GE Healthcare) and held senior financial positions at VeloBind (Manufacturing) and Precision Echo (Defense Manufacturer), both public companies. Mr. Franklin received a BS in Business from the University of Southern California and an MBA from Santa Clara University.
NEIL C. BARMAN, MD Chief Scientific Officer
Neil Barman joined ReCor Medical in November 2017.
Prior to joining ReCor, Dr. Barman co-founded AblaCare, a start-up medical device company focused on infertility due to polycystic ovary syndrome. Prior to this, Dr. Barman was an early employee and part of the senior management team at Ardian. Ardian pioneered the field of catheter-based renal denervation and was acquired by Medtronic in January 2011. Previously, Dr. Barman led the clinical/medical team at Concentric Medical that developed the first FDA approved line of embolectomy catheters for ischemic stroke. He started his medical device career at Radiant Medical investigating catheter-based cooling for heart attack and stroke. Dr. Barman graduated Phi Beta Kappa with a B.S. in Biology from Stanford University. He earned his M.D. from Northwestern University Medical School. During medical school, Dr. Barman also did coursework at the Kellogg School of Management.
RICK FELLER, Chief Operating Officer
Rick Feller joined ReCor Medical in March of 2022.
Mr. Feller brings over 20 years of leadership experience in medical device development specifically in the areas of R&D, manufacturing development, clinical research, and program management. He began his professional career with Cordis where he led the development of many peripheral interventional products from early-stage concepts through PMA approval. He later expanded his leadership as V.P. of R&D and Manufacturing Development for ev3 in the development of interventional devices treating both peripheral arterial and venous disease. Through subsequent acquisitions by Covidien and then Medtronic, he expanded his responsibilities to manage a global R&D team across the United States and Europe. He later joined Wright Medical as V.P. of R&D and Clinical Research for their shoulder arthroplasty business until an acquisition by Stryker. Mr. Feller is a graduate of the University of Florida with a BS and MS in Materials Science & Engineering.
HELEN REEVE-STOFFER, Ph.D Vice President, Clinical Affairs
Helen Reeve-Stoffer joined ReCor Medical in June 2013.
Dr. Reeve-Stoffer has more than 15 years of experience of global clinical and Medical Affairs program development in the medical device industry preceded by an additional 9 years in academic research and teaching. Most recently Dr. Reeve-Stoffer served as CRM Clinical Director for New Product Development and Low Voltage platforms for Boston Scientific Inc. where she was responsible for the pre and post-launch clinical evidence and regulatory program strategies. She also held the position of International Director of Medical Affairs and Education at Cameron Health BV and prior to that had several US and International-based clinical positions for Guidant Corporation including project management, technical field support for all study phases and the development of country-specific clinical business strategies. She began her academic career as an Assistant Professor at the University of Minnesota. Dr. Reeve-Stoffer earned her PhD and BSc in Pharmacology at the University of Leeds, Leeds UK.
LESLIE COLEMAN, DVM, MS, DACLAM Vice President, Regulatory & Medical Affairs
Leslie Coleman joined ReCor Medical in May 2013.
Dr. Coleman has more than 15 years of experience in the medical device industry in medical affairs, preclinical and clinical research, and over 10 years of veterinary medicine. Prior to joining ReCor Medical, Dr. Coleman served as Director, Medical Affairs at Abbott Vascular Structural Heart. Previously, Dr. Coleman was Director, PreClinical Research at Abbott Vascular and Guidant Corporation where she was a key contributor towards numerous research and development projects to treat coronary artery disease. Dr. Coleman has contributed towards the development of several drug eluting stent platforms through PMA submission, FDA Advisory panel meeting and PMA approval. Dr. Coleman received a Doctorate of Veterinary Medicine at the University of California, Davis, a Masters of Science in Toxicology from the Massachusetts Institute of Technology, and is a Diplomate of the American College of Laboratory Animal Medicine.
DAVE HAUGAARD Vice President, Operations
Dave Haugaard joined ReCor Medical in September 2018.
Mr. Haugaard brings over 20 years of experience in operational leadership in the development and commercialization of innovative Medical Devices for underserved patients. Previously, Mr. Haugaard was Vice President of Operations at Elixir Medical, a start-up coronary drug eluting stent company where he developed and commercially launched numerous bioabsorbable and metallic stent systems. Prior to this, he was Senior Director of Operations at Conor Medsystems, a drug-eluting stent company acquired by Johnson and Johnson in February 2007 and Director of Operations for Broncus Technologies, which developed devices for interventional pulmonology. During his career Mr. Haugaard has led both domestic and international operations teams from development and through commercialization. He received his BS in Mechanical Engineering from Oregon State University.
FAISAL KHAN Vice President, Marketing
Faisal Khan joined ReCor Medical in January 2019.
Mr. Khan has over 18 years experience spread across management consulting, technology and healthcare. Within medical devices, Mr. Khan as built and led high performing marketing teams in cardiovascular, peripheral vascular, and neurovascular markets. Mr. Khan started his career as a management consultant at PricewaterhouseCoopers and then IBM, leading consulting projects exceeding $1 billion in revenue at clients such as Pfizer. Mr. Khan went on to work in positions of increasing leadership at companies such as Cordis, Abbott Vascular and Stryker Neurovascular, managing global launches of both line extensions and disruptive innovations in the access, intervention and closure categories. Mr. Khan has a Bachelor’s degree in Systems Engineering from the University of Virginia, and an MBA from the University of Chicago Booth School of Business.
DAVID KIM Vice President, Quality Affairs
David Kim joined ReCor Medical in June 2015.
Mr. Kim has 20 years experience with increasing responsibility in quality assurance systems and engineering. Mr. Kim began his quality career at Perclose following the acquisition by Abbott Laboratories, where he lead the site implementation of corporate quality and compliance directives. Following that experience, he worked at several rapidly growing medical device companies including Conor MedSystems where he was part of evolving the quality system to meet the demands of an expanding organization while maintaining a collaborative and innovative culture of compliance. More recently, Mr. Kim has been the first quality employees at several early stage companies including Moximed and Altura Medical, where he was responsible for rapidly establishing the quality system and obtaining ISO certification. Mr. Kim is a graduate of the University of Southern California with a Bachelor of Science in Biomedical Engineering.